DELRAY BEACH, Fla., Jan. 04, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal (GI) diseases, today …
See Original Article

KANSAS CITY, MO (KCTV) — The FDA is meeting this week to consider giving half-doses of Moderna’s COVID-19 vaccine to people ages 18 to 55. The head of Operation Warp Speed says clinical data shows the vaccine can be just as effective at half-doses …
See Original Article

Focusing on what you can control is one of the best ways to manage your money. Investors often fail to recognize the aspects of their financial situation that are within their control. For example, if asked why you don’t have more extra cash leftover each year, …
See Original Article

Centene will pay $95 a share in cash, according to a statement on Monday, or 15% above Magellan Health’s closing price on Thursday. The purchase will be primarily funded with debt, and JPMorgan Chase & Co. has provided a bridge financing commitment.
See Original Article

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 4, 2021 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics, will …
See Original Article